Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Inozyme Pharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −2 vs. Q1 2022
- Shares held
- 31.5M
- +14.1M (+81.3%) vs. Q1 2022
- Total value
- $149.4M
- +$78.2M (+109.8%) vs. Q1 2022
- New holders
- 13
- 18 more added
- Sold out
- 15
- 14 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 87 | $202.3M |
| Q1 2025 | 97 | $42.5M |
| Q4 2024 | 105 | $145.1M |
| Q3 2024 | 89 | $285.5M |
| Q2 2024 | 90 | $240.1M |
| Q1 2024 | 89 | $382.0M |
| Q4 2023 | 80 | $213.3M |
| Q3 2023 | 77 | $204.6M |
| Q2 2023 | 74 | $190.3M |
| Q1 2023 | 50 | $183.4M |
| Q4 2022 | 37 | $30.4M |
| Q3 2022 | 39 | $82.7M |
| Q2 2022 | 47 | $149.4M |
| Q1 2022 | 50 | $71.2M |
| Q4 2021 | 51 | $118.2M |
| Q3 2021 | 52 | $202.7M |
| Q2 2021 | 50 | $337.1M |
| Q1 2021 | 55 | $379.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 60 | $0 | 0.00% | −310,873−100.0% | Reduced |
| Bank of America Corp | 7 | $0 | 0.00% | −6,640−99.9% | Reduced |
| Ellevest, Inc. | 76 | $0 | 0.00% | +38+100.0% | Added |
| Credit Suisse AG | 8 | $0 | 0.00% | +8 | New |
| Citigroup Inc | 143 | $1.00K | 0.00% | −12,374−98.9% | Reduced |
| UBS Group AG | 115 | $1.00K | 0.00% | −6,198−98.2% | Reduced |
| New York State Common Retirement Fund | 117 | $1.00K | 0.00% | −3,717−96.9% | Reduced |
| Wells Fargo & Company | 177 | $1.00K | 0.00% | −2,778−94.0% | Reduced |
| Crewe Advisors LLC | 163 | $1.00K | 0.00% | +163 | New |
| Royal Bank of Canada | 469 | $2.00K | 0.00% | −415−46.9% | Reduced |
| Nisa Investment Advisors, LLC | 4,800 | $23.0K | 0.00% | +4,800 | New |
| Barclays PLC | 6,403 | $31.0K | 0.00% | −2,337−26.7% | Reduced |
| Virtu Financial LLC | 11,179 | $53.0K | 0.00% | +11,179 | New |
| Goldman Sachs Group Inc | 12,505 | $60.0K | 0.00% | −750−5.7% | Reduced |
| Dimensional Fund Advisors LP | 13,087 | $63.0K | 0.00% | +13,087 | New |
| Charles Schwab Investment Management Inc | 16,549 | $79.0K | 0.00% | −13,948−45.7% | Reduced |
| Bank of New York Mellon Corp | 21,898 | $105.0K | 0.00% | −18,115−45.3% | Reduced |
| Ergoteles LLC | 25,649 | $122.0K | 0.00% | +25,649 | New |
| Morgan Stanley | 41,174 | $197.0K | 0.00% | +25,237+158.4% | Added |
| Northern Trust Corp | 46,990 | $224.0K | 0.00% | −66,833−58.7% | Reduced |
| State Street Corp | 49,055 | $234.0K | 0.00% | −139,950−74.0% | Reduced |
| State of Wisconsin Investment Board | 68,900 | $329.0K | 0.00% | +68,900 | New |
| Overbrook Management Corp | 69,326 | $331.0K | 0.10% | +52,600+314.5% | Added |
| Bridgeway Capital Management, LLC | 87,400 | $417.0K | 0.01% | +30,000+52.3% | Added |
| Walleye Capital LLC | 101,442 | $484.0K | 0.01% | +101,442 | New |
| Baker Bros. Advisors LP | 106,999 | $510.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 118,300 | $564.0K | 0.00% | +106,400+894.1% | Added |
| Citadel Advisors LLC | 120,827 | $577.0K | 0.00% | +22,530+22.9% | Added |
| UBS Oconnor LLC | 171,347 | $817.0K | 0.01% | +171,347 | New |
| Millennium Management LLC | 173,092 | $826.0K | 0.00% | +173,092 | New |
| Geode Capital Management, LLC | 216,925 | $1.03M | 0.00% | +30,918+16.6% | Added |
| Laurion Capital Management LP | 271,800 | $1.30M | 0.05% | +261,800+2,618.0% | Added |
| BlackRock Inc. | 430,520 | $2.05M | 0.00% | −447,880−51.0% | Reduced |
| FMR LLC | 609,819 | $2.91M | 0.00% | +2250.0% | Added |
| MPM Oncology Impact Management LP | 664,980 | $3.17M | 0.88% | +370,000+125.4% | Added |
| Janus Henderson Group PLC | 929,956 | $4.46M | 0.00% | +409,193+78.6% | Added |
| Sphera Funds Management Ltd. | 1,165,600 | $5.56M | 1.06% | +1,165,600 | New |
| Vanguard Group Inc | 1,354,216 | $6.46M | 0.00% | +864,603+176.6% | Added |
| CHI Advisors LLC | 2,033,802 | $9.70M | 3.71% | +1,141,745+128.0% | Added |
| NEA Management Company, LLC | 2,444,379 | $10.5M | 0.54% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,546,672 | $12.1M | 0.03% | +800,000+45.8% | Added |
| Rock Springs Capital Management LP | 2,640,056 | $12.6M | 0.37% | +1,446,861+121.3% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,661,154 | $12.7M | 6.39% | +1,070,000+67.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,696,372 | $12.9M | 0.27% | +351,586+15.0% | Added |
| VR Adviser, LLC | 2,709,987 | $12.9M | 2.55% | +2,709,987 | New |
| Deep Track Capital, LP | 3,250,000 | $15.5M | 1.07% | +3,250,000 | New |
| Sofinnova Investments, Inc. | 3,655,308 | $17.4M | 1.55% | +1,627,000+80.2% | Added |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −1,013,216−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −43,574−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −12,890−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,350−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,916−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −10,273−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −7,810−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,144−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,996−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,430−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,732−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,147−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −692−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −451−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |